Hydronephrosis Complicating Endometriosis in a Case of Infiltrating Lobular Carcinoma of the Breast Treated with TamoxifenPeter Graham1* and Najmun Nahar2
- Corresponding Author:
- Peter Graham
Cancer Care Centre, St George Hospital
Kogarah, NSW, Australia 2145
Tel: +61 2 91133909
Fax: +61 2 91133958
E-mail: [email protected]
Received Date: June 24, 2014; Accepted Date: August 10, 2014; Published Date: August 15, 2014
Citation: Graham P, Nahar N (2014) Hydronephrosis Complicating Endometriosis in a Case of Infiltrating Lobular Carcinoma of the Breast Treated with Tamoxifen. Gynecol Obstet (Sunnyvale) 4: 235. doi: 10.4172/2161-0932.1000235
Copyright: © 2014 Graham P, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Uterine endometrialpolyp, hyperplasia and malignant transformation are well known side effects of Tamoxifen use in breast cancer patients. We present a case of hydronephrosis secondary to extra-uterine endometriosis in a female with mixed Invasive Ductal Carcinoma (IDC) and Invasive Lobular Carcinoma (ILC) of the breast on adjuvant tamoxifen.